Free Float 4,24 %
Shares Float 213,00
Shares Outstanding 5.044,00
Eurofins-Cerep S.A.
Share · FR0013256518 (XPAR)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Eurofins-Cerep S.A.
No Price
Share Float & Liquidity
Company Profile for Eurofins-Cerep S.A. Share
Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.
Company Data
Name Eurofins-Cerep S.A.
Company Eurofins-Cerep S.A.
Website
https://www.eurofins.fr/cerep
Primary Exchange 
Paris
Paris
ISIN FR0013256518
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Damien Vielliard
Market Capitalization 81 Mio
Country France
Currency EUR
Employees 0,2 T
Address Le Bois l'Evêque, 86600 Vienne
IPO Date 2000-04-12
Stock Splits
| Date | Split |
|---|---|
| 27.07.2017 | 1:50 |
| 02.01.2015 | 1:50 |
| 30.07.2001 | 5:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Paris | ALECR.PA |
More Shares
Investors who hold Eurofins-Cerep S.A. also have the following shares in their portfolio:
